Kevin Bateman

Dr. Kevin Bateman

Merck & Co., Inc
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2015 in Science
Verified
Journal Article
Closed access
PDF file
ASAlexander Buitrago Santanilla
Alexander Buitrago Santanilla
ERErik L. Regalado
Erik L. Regalado
TPTony Pereira
Tony Pereira
MSMichael Shevlin
Michael Shevlin
KBKevin Bateman
Kevin Bateman
SDSpencer D. Dreher
Spencer D. Dreher
Breaking through the milligram floor: When chemists synthesize compounds, the threshold for success is at least a milligram of product. This has been true for decades—even though biochemical assays have long since descended into microgram territory—and results in part from the constraints of characterization methods. Buitrago Santanilla et al. present an automated dosing and characterization protocol for optimizing chemical reaction conditions on the microgram scale. This allowed them to screen numerous base and ligand combinations for catalytic C-N bond-forming reactions between complex pairs of compounds, in short supply, that resisted standard coupling conditions. Science , this issue p. 49

29 March 2007 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
KBKevin Bateman
Kevin Bateman
JCJose Castro‐Perez
Jose Castro‐Perez
MWMark Wrona
Mark Wrona
JSJohn P. Shockcor
John P. Shockcor
KYKate Yu
Kate Yu
DNDeborah A. Nicoll‐Griffith
Deborah A. Nicoll‐Griffith

1 June 2004 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JGJocelyne Guay
Jocelyne Guay
KBKevin Bateman
Kevin Bateman
RGRobert Gordon
Robert Gordon
JMJoseph Mancini
Joseph Mancini
DRDenis Riendeau
Denis Riendeau
Peripheral inflammation involves an increase in cyclooxygenase-2 (COX-2)-mediated prostaglandin (PG) synthesis in the central nervous system (CNS), which contributes to allodynia and hyperalgesia. In the present study we have determined the changes in prostanoid tissue levels and in expression of terminal prostanoid synthases in both the CNS and inflamed peripheral tissue during carrageenan-induced paw inflammation in the rat. Prostanoid levels were measured by liquid chromatography-mass spectrometry and enzyme expression at the RNA level by quantitative PCR analysis during both the early (1-6 h) and late (12 and 24 h) phases of the inflammatory response. In the paw, the early phase was associated with increases in PGE(2) and thromboxane (TX)B(2) levels and with a peak of COX-2 expression that preceded that of microsomal prostaglandin-E(2) synthase-1 (mPGES-1). COX-2 and mPGES-1 remained elevated during the late phase, and PGE(2) continued to further increase through 24 h. The cytosolic PGE(2) synthase (cPGES) showed a small transient increase during the early phase, whereas mPGES-2 expression was not affected by inflammation. In the cerebrospinal fluid, elevated levels of PGE(2), 6-keto-PGF(1alpha), PGD(2), and TXB(2) were detected during the early phase. PGE(2) levels also increased in the spinal cord and, to a lesser extent, in the brain and remained elevated in both the cerebrospinal fluid and the spinal cord during the late phase. The expression of mPGES-1 was strongly up-regulated in the brain and spinal cord during inflammation, whereas no change was detected for the expression of cPGES, mPGES-2, COX-1, and terminal PGD, TX, or PGI synthases. The results show that the carrageenan-induced edema in the paw elicits an early phase of COX-2 induction in the CNS leading to an increase synthesis in PGD(2), 6-keto-PGF(1alpha), and TXB(2) in addition to the major PGE(2) response. The data also indicate that the up-regulation of mPGES-1 contributes to COX-2-mediated PGE(2) production in the CNS during peripheral inflammation.

6 March 2009 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
KBKevin Bateman
Kevin Bateman
MKMarkus Kellmann
Markus Kellmann
HMHelmut Muenster
Helmut Muenster
RPRobert Papp
Robert Papp
LTLester Taylor
Lester Taylor

16 August 2005 in Rapid Communications in Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
MWMark Wrona
Mark Wrona
TMTimo Mauriala
Timo Mauriala
KBKevin Bateman
Kevin Bateman
RMRussell J. Mortishire‐Smith
Russell J. Mortishire‐Smith
DODesmond O'COnnor
Desmond O'COnnor

20 January 2007 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CSClaudio F. Sturino
Claudio F. Sturino
GOGary O'NEill
Gary O'NEill
NLNicolas Lachance
Nicolas Lachance
MBMichael Boyd
Michael Boyd
CBCarl Berthelette
Carl Berthelette
KMKathleen M. Metters
Kathleen M. Metters